Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Payments for Repurchase of Initial Public Offering

2.8 / 5 stars · 68/120 Roast Me

HYPERION DEFI, INC. Payments for Repurchase of Initial Public Offering

HYPERION DEFI, INC. (HYPD) reported Payments for Repurchase of Initial Public Offering of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2020-03-30

  • HYPERION DEFI, INC. payments for repurchase of initial public offering for the quarter ending 2019-12-31 was $0.00.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for the quarter ending 2019-09-30 was $0.00.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for the quarter ending 2019-06-30 was $0.00.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for fiscal 2018 was $345.50K, a 76.54% increase from fiscal 2017.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for fiscal 2017 was $195.70K.
  • HYPERION DEFI, INC. payments for repurchase of initial public offering for fiscal 2016 was $0.00.
Period endPayments for Repurchase of Initial Public Offering 3 monthPayments for Repurchase of Initial Public Offering 6 monthPayments for Repurchase of Initial Public Offering 9 monthPayments for Repurchase of Initial Public Offering 12 month
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$0.00
derived: sum of 2 quarters · filed 2020-03-30
$0.00
derived: sum of 3 quarters · filed 2020-03-30
$0.00
10-K · filed 2020-03-30
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$0.00
derived: sum of 2 quarters · filed 2019-11-13
$0.00
10-Q · filed 2019-11-13
$0.00
derived: sum of 4 quarters · filed 2020-03-30
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$0.00
10-Q · filed 2019-08-13
$0.00
derived: sum of 3 quarters · filed 2020-03-30
$0.00
derived: sum of 4 quarters · filed 2020-03-30
2019-03-31$0.00
10-Q · filed 2019-05-14
$0.00
derived: sum of 2 quarters · filed 2020-03-30
$0.00
derived: sum of 3 quarters · filed 2020-03-30
$0.00
derived: sum of 4 quarters · filed 2020-03-30
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$0.00
derived: sum of 2 quarters · filed 2020-03-30
$0.00
derived: sum of 3 quarters · filed 2020-03-30
$345.50K
10-K · filed 2020-03-30
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$0.00
derived: sum of 2 quarters · filed 2019-11-13
$345.50K
10-Q · filed 2019-11-13
$459.96K
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$345.50K
10-Q · filed 2019-08-13
$459.96K
derived: sum of 3 quarters · filed 2019-08-13
$541.20K
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$345.50K
10-Q · filed 2019-05-14
$459.96K
derived: sum of 2 quarters · filed 2019-05-14
$541.20K
derived: sum of 3 quarters · filed 2019-05-14
$541.20K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$114.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27
$195.70K
derived: sum of 2 quarters · filed 2019-03-27
$195.70K
derived: sum of 3 quarters · filed 2019-03-27
$195.70K
10-K · filed 2019-03-27
2017-09-30$81.24K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$81.24K
derived: sum of 2 quarters · filed 2018-11-13
$81.24K
10-Q · filed 2018-11-13
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$0.00
10-Q · filed 2018-08-14
2017-03-31$0.00
10-Q · filed 2018-05-09
2016-12-31$0.00
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76